ALFA Finder
12:07 IST
BSE
Earnings Call
Indegene Earnings Call Transcript: Key Takeaways
Strong top-line growth driven by pharma digital transformation, but near-term margins are compressed by annual wage hikes and mutual fund mark-downs.
Indegene Ltd
- Share price
- ₹616.00
- Market cap
- ₹14,841 Cr
- Revenue (annual)
- ₹3,510 Cr
- Net profit (annual)
- ₹401.1 Cr
- P/E (TTM)
- 36.1×Sector 54.5×
- Promoter holding
- 0.00%+0.00% QoQ
- FII holding
- 12.40%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Earnings Call 6Legal & Regulatory 4Employee Stock Options 4Business Update 4Other Announcement 3Management Change 3Results Update 2Merger & Restructuring 2Financial Results 2Board Meeting Date 2Annual General Meeting 2Dividend 1Capital Structure Change 1
Time
6 announcements with these filters
20:07 IST
BSE
Earnings Call
Indegene Investor Presentation: Key Takeaways
Q2 FY27 revenue INR 11,223M (+39.5% YoY, +5.6% QoQ), EBITDA margin 16.7%, PAT INR 1,123M (+10% YoY). BioPharm integration ahead of plan.
12:30 IST
BSE
Earnings Call
Indegene Earnings Call Transcript: Key Takeaways
Indegene delivered its strongest Q1 growth in four years, yet remains burdened by elevated costs from strategic investments and workforce transformation.
19:35 IST
BSE
Earnings Call
Indegene Investor Presentation: Key Takeaways
Indegene reported Q1'FY27 revenue of ₹10,631M (+39.7% YoY) with an EBITDA margin of 16.9%. The strategy focuses on scaling GenAI-powered solutions and deepening engagement with large pharma.
13:51 IST
NSE
Earnings Call
Indegene Earnings Call: Key Takeaways
Indegene reported FY26 revenue of INR 35,105M with 19.4% adjusted EBITDA margin, positioning itself as an AI-embedded specialist displacing traditional agencies and CROs in life sciences.
20:07 IST
NSE
Earnings Call
Indegene Earnings Call: Key Takeaways
Indegene positions as an AI-embedded operating partner for life sciences. Reported FY26 revenue of INR 35.1Bn with 19.4% EBITDA margins and 29.4% CAGR.